Evidence Based Birth®

Dr. Rebecca Dekker and EBB Research Fellow Morgan Richardson Cayama tackle your questions about the ARRIVE trial and elective inductions at 39 weeks. They explore the evidence behind this controversial study, discuss the implications for Cesarean rates, and unpack the concept of patient autonomy in maternity care. Plus, they share practical tips for managing pressure to induce and delve into how the ARRIVE trial impacts outcomes like breastfeeding, epidurals, and costs. Tune in to hear this Q&A session originally broadcast to listeners worldwide.   Episode 334: The ARRIVE Trial and Elective Induction at 39 Weeks (03:38) How often are we seeing pressure from obstetricians to induce? (07:20) How can you manage pressure from an obstetrician to get an induction at 39 weeks? (12:00) What are the geographic trends in induction rates? (15:30) What are the statistics on infant death and mortality? (19:56) What happens if a midwife or obstetrician refuses a 39-week elective induction requested b